Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 342 (RNA5SP342) is a non-coding, processed rRNA pseudogene found in the human genome[8][10][2]. It is homologous to the functional 5S ribosomal RNA sequence but contains mutations or sequence disruptions that prevent it from encoding a functional 5S rRNA molecule. Like other pseudogenes, it is generally considered inactive and does not contribute to ribosomal structure or function. Unlike canonical 5S rRNA genes, RNA5SP342 does not participate in ribosome assembly, protein synthesis, or cellular signaling[1][3][15]. There is no evidence that RNA5SP342 is implicated in disease, therapeutic targeting, or diagnostic applications. Most genomic databases annotate RNA5SP342 and similar pseudogenes for completeness of genome coverage and evolutionary studies, and not because they have established biological or clinical roles[8][10][2][4].
Not applicable. No drugs target RNA5SP342 or similar rRNA pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 342 (RNA5SP342).